Employees of companies at Industriepark Höchst must go through a one-time registration process to gain access to the extranet with its park news, current messages, contact details and other services.
You only need to enter your business e-mail address to register. We will follow our data privacy policy whenever using the data provided in your profile.
Infraserv Höchst's customers can also register.
You can also access the extranet from a tablet, smartphone or other devices if you provide a business e-mail address and a password.
Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates, with programs spanning oncology, neuromuscular, cardiopulmonary, and virology indications.
Dewpoint scientists work in Boston, Dresden, and Frankfurt to translate condensate biology into treatments for the toughest diseases.
